Last update :
19/09/2022
References   References 4665  
Type : Manufacturer

Research teams :
Authors :
Title : LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021
Reference : Sanofi Aventis 2021

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionAlemtuzumab Anticancer drug
Stability in solutions Not specified NaCl 0,9% or Glucose 5% 0.1 mg/ml 2-8°C Protect from light
8 Hour

  Mentions Légales